Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glantreo is a specialist material science company based in Cork, Ireland, that focuses on the development and manufacture of advanced silica-based materials for the life sciences and diagnostic industries. The company provides a range of high-performance chromatography media, mesoporous silica, and magnetic nanoparticles used in applications such as protein purification, drug delivery, and molecular diagnostics. Glantreo operates as both a product provider and a contract research and manufacturing partner, leveraging its expertise in particle engineering to solve complex material challenges for global pharmaceutical and biotech clients. Their portfolio includes proprietary technologies for sub-2 micron silica and functionalized nanoparticles designed to enhance analytical and therapeutic outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glantreo.